Prospera Financial Services Inc Novartis Ag Transaction History

Prospera Financial Services Inc

  • $4.16 Billion
  • Q4 2024

A detailed history of Prospera Financial Services Inc transactions in Novartis Ag stock. As of the latest transaction made, Prospera Financial Services Inc holds 17,611 shares of NVS stock, worth $1.96 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
17,611
Previous 17,127 2.83%
Holding current value
$1.96 Million
Previous $1.97 Million 13.0%
% of portfolio
0.04%
Previous 0.05%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$96.78 - $117.18 $46,841 - $56,715
484 Added 2.83%
17,611 $1.71 Million
Q3 2024

Nov 07, 2024
BUY
$106.13 - $120.89 $106 - $120
1 Added 0.01%
17,127 $1.97 Million
Q2 2024

Aug 13, 2024
SELL
$92.57 - $107.37 $20,828 - $24,158
-225 Reduced 1.3%
17,126 $1.82 Million
Q1 2024

Aug 13, 2024
BUY
$95.27 - $108.47 $28,199 - $32,107
296 Added 1.73%
17,422 $1.69 Million
Q4 2023

Feb 14, 2024
BUY
$92.27 - $101.54 $351,733 - $387,070
3,812 Added 28.16%
17,351 $1.75 Million
Q3 2023

Nov 13, 2023
BUY
$94.73 - $105.13 $43,386 - $48,149
458 Added 3.5%
13,539 $1.38 Million
Q2 2023

Aug 08, 2023
BUY
$92.52 - $104.91 $186,705 - $211,708
2,018 Added 18.24%
13,081 $1.32 Million
Q1 2023

May 12, 2023
BUY
$80.03 - $92.81 $136,371 - $158,148
1,704 Added 18.21%
11,063 $1.02 Million
Q4 2022

Feb 08, 2023
SELL
$75.55 - $92.52 $60,893 - $74,571
-806 Reduced 7.93%
9,359 $849,000
Q3 2022

Oct 27, 2022
BUY
$74.61 - $87.26 $226,441 - $264,834
3,035 Added 42.57%
10,165 $774,000
Q2 2022

Aug 08, 2022
SELL
$80.52 - $93.75 $241 - $281
-3 Reduced 0.04%
7,130 $604,000
Q1 2022

May 04, 2022
SELL
$80.11 - $90.62 $395,262 - $447,119
-4,934 Reduced 40.89%
7,133 $627,000
Q4 2021

Feb 10, 2022
SELL
$79.7 - $88.13 $414,918 - $458,804
-5,206 Reduced 30.14%
12,067 $1.06 Million
Q3 2021

Nov 12, 2021
BUY
$81.78 - $95.14 $23,879 - $27,780
292 Added 1.72%
17,273 $1.41 Million
Q2 2021

Aug 12, 2021
SELL
$85.24 - $94.15 $938,236 - $1.04 Million
-11,007 Reduced 39.33%
16,981 $1.55 Million
Q1 2021

May 06, 2021
BUY
$83.5 - $98.47 $128,172 - $151,151
1,535 Added 5.8%
27,988 $2.39 Million
Q4 2020

Feb 12, 2021
BUY
$78.07 - $94.43 $2.05 Million - $2.48 Million
26,267 Added 14122.04%
26,453 $2.5 Million
Q3 2020

Nov 04, 2020
SELL
$82.14 - $91.0 $1.97 Million - $2.19 Million
-24,033 Reduced 99.23%
186 $16,000
Q2 2020

Aug 07, 2020
BUY
$80.93 - $91.1 $101,243 - $113,966
1,251 Added 5.45%
24,219 $2.12 Million
Q1 2020

May 15, 2020
BUY
$70.67 - $99.01 $178,371 - $249,901
2,524 Added 12.35%
22,968 $1.89 Million
Q4 2019

Feb 12, 2020
BUY
$84.35 - $95.37 $925,150 - $1.05 Million
10,968 Added 115.75%
20,444 $1.94 Million
Q3 2019

Oct 22, 2019
SELL
$85.54 - $94.26 $72,965 - $80,403
-853 Reduced 8.26%
9,476 $824,000
Q2 2019

Aug 14, 2019
SELL
$75.4 - $92.8 $174,174 - $214,368
-2,310 Reduced 20.67%
8,864 $761,000
Q2 2019

Aug 14, 2019
BUY
$75.4 - $92.8 $110,461 - $135,952
1,465 Added 16.53%
10,329 $937,000
Q1 2019

May 02, 2019
BUY
$75.32 - $86.15 $173,989 - $199,006
2,310 Added 26.06%
11,174 $1.06 Million
Q4 2018

Feb 13, 2019
BUY
$73.66 - $82.02 $222,084 - $247,290
3,015 Added 51.55%
8,864 $761,000
Q3 2018

Oct 25, 2018
SELL
$66.94 - $77.43 $30,256 - $34,998
-452 Reduced 7.17%
5,849 $491,000
Q2 2018

Jul 18, 2018
SELL
$64.91 - $73.36 $30,702 - $34,699
-473 Reduced 6.98%
6,301 $484,000
Q1 2018

Apr 12, 2018
SELL
$70.39 - $84.15 $30,830 - $36,857
-438 Reduced 6.07%
6,774 $548,000
Q4 2017

Jan 24, 2018
SELL
$72.33 - $77.64 $31,897 - $34,239
-441 Reduced 5.76%
7,212 $614,000
Q3 2017

Oct 11, 2017
BUY
$74.14 - $77.27 $567,393 - $591,347
7,653
7,653 $658,000

Others Institutions Holding NVS

# of Institutions
1,478
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $239B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email